Market Research Future

Influenza Vaccination Market Application Overview, Industry Analysis and Forecast 2016-2022


Pune, India -- (SBWIRE) -- 07/20/2017 -- Market Scenario:

The market for Influenza vaccination is booming, as Influenza (flu) is a contagious respiratory disease that is caused by influenza viruses. Influenza viruses infect the respiratory tract (nose, throat, and lungs) in humans. The symptoms and complications of flu are more severe than common cold.

Influenza usually comes on suddenly and may include symptoms such as fever, headache, malaise, cough, sore throat, nasal congestion and body aches. Yearly influenza vaccine can prevent lot of illness and death caused by influenza virus. Influenza vaccine can be given to most individuals 6 months of age and older to protect against influenza.

Request a Sample Report @

Major Key Players

- Abbott Laboratories
- Astrazeneca PLC
- Biocryst Pharmaceuticals
- CSL Limited
- Daiichi Sankyo Co., Ltd.
- Glaxosmithkline PLC
- Instituto Butantan
- Japan Vaccine Co., Ltd.
- Mitsubishi Tanabe Pharma Corporation
- Nanotherapeutics Inc.
- Protein Sciences Corporation
- Roche Holding AG
- Sanofi SA
- Serum Institute of India Pvt Ltd

The report for Global Influenza vaccination Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance.

Taste the market data and market information presented through more than 50 market data tables and figures spread in 80 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on "Global Influenza Vaccination Market Research Report- Forecast To 2022"

Access Report Details @

Intended Audience

- Influenza Vaccine manufacturers
- Influenza Vaccine suppliers
- Research and Development (R&D) Companies
- Government Research Laboratories
- Independent Research Laboratories
- Government and Independent Regulatory Authorities
- Market Research and Consulting Service Providers
- Medical Research Laboratories
- Academic Medical Institutes and Universities

Global Influenza vaccination market has been segmented on the basis of Influenza type which comprises of seasonal, pandemic and zoonotic. On the basis of manufacturing technology, market is segmented into egg based technology; cell culture based technology, recombinant technology. On the basis of end user, market is segmented into hospital, ambulatory, research laboratory and others.

The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.

Browse Related Statistical Report

Asia-Pacific Dental Consumables Market, is projected to grow at a CAGR of 7.0% and is expected to reach US$ 5,5396.6 million by 2024. In Asia-Pacific Dental Consumables Market, Japan accounted for the largest market share in 2015.

About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact Info:
Name: Akash Anand
Organization: Market Research Future
Address: Market Research Future Office No. 524/528,
Phone: +1 646 845 9312